Inventor
VASH BRIAN EDWARD
US17 patents
⚠️ This page may combine multiple inventors who share the name “VASH BRIAN EDWARD”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MARENGO THERAPEUTICS INC
13 patentsUS11291721B2Apr 5, 2022
Multispecific and multifunctional molecules and uses thereof
MARENGO THERAPEUTICS INC15 citations85
US11965025B2Apr 23, 2024
Method of treating solid cancers with bispecific interleukin-anti-TCRß molecules
MARENGO THERAPEUTICS INC7 citations83
US11845797B2Dec 19, 2023
Anti-TCR antibody molecules and uses thereof
MARENGO THERAPEUTICS INC7 citations83
US12351632B2Jul 8, 2025
Anti-TCR antibody molecules and uses thereof
MARENGO THERAPEUTICS INC1 citations72
US12286477B2Apr 29, 2025
Anti-TCR antibody molecules and uses thereof
MARENGO THERAPEUTICS INC1 citations72
US12152073B2Nov 26, 2024
Multifunctional molecules that bind to calreticulin and uses thereof
MARENGO THERAPEUTICS INC4 citations66
US12247060B2Mar 11, 2025
Calreticulin binding constructs and engineered T cells for the treatment of diseases
MARENGO THERAPEUTICS INC1 citations63
US12486326B2Dec 2, 2025
Anti-TCR antibody molecules and uses thereof
MARENGO THERAPEUTICS INC1 citations60
US12421323B2Sep 23, 2025
Multispecific antibody molecules comprising lambda and kappa light chains
MARENGO THERAPEUTICS INC0 citations59
US11673971B2Jun 13, 2023
Multispecific antibody molecules comprising lambda and kappa light chains
MARENGO THERAPEUTICS INC1 citations59
US12384842B2Aug 12, 2025
Antibody molecules that bind to NKP30 and uses thereof
MARENGO THERAPEUTICS INC1 citations58
US12134654B2Nov 5, 2024
Multispecific molecules and uses thereof
MARENGO THERAPEUTICS INC0 citations49
US12358982B2Jul 15, 2025
Multifunctional molecules that bind to T cell related cancer cells and uses thereof
MARENGO THERAPEUTICS INC0 citations47